Clinical Trials List

On-going Clinical Trials

Working with internationally-respected medical institutions to develop R&D investigations and formal clinical trials in the United States.

UPMC Ovarian Cancer Study

University of Louisville; Worcester Polytechnic Breast Cancer Study

Investigations on Non-Small Cell Lung Cancer Screening

Over 200 patent applications filed globally with 107 patent applications issued.*

Our patented Cancer Differentiation Analysis (CDA) technology reinvents cancer screening and early detection with a “Blood Biopsy” that has no side effects in patients.

How CDA Technology Works

*Patents granted to date.

“game changing”

Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.

Read the full article

Quick Links

Contact Information

Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002

Email: [email protected]

Phone Number: +1 (267) 810-6776

Anpac Bio-Medical Science Co., Ltd.

Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.